Market Place
Sourcing Support
Strides Acquires Sandoz Generic Brands to Boost Africa Business
17 Mar 2026 //
PRESS RELEASE
Sandoz Introduces Cost-Effective Iron Sucrose Injection
24 Sep 2025 //
BUSINESSWIRE
Sandoz Resolves US Generic Drug Antitrust Litigation
17 Dec 2024 //
GLOBENEWSWIRE
Sandoz US launches generic paclitaxel in single-dose vial
11 Oct 2024 //
GLOBENEWSWIRE
Ex-Sandoz exec gets probation for price-fixing after cooperation deal
16 May 2024 //
REUTERS
Sandoz US subsidiaries resolve generic drug antitrust class action litigation
29 Feb 2024 //
GLOBENEWSWIRE
Novartis unveils new brand identity after Sandoz spinoff
06 Dec 2023 //
ENDPTS
Sandoz enters new era as standalone global leader
04 Oct 2023 //
PRESS RELEASE
Sandoz inks deal to commercialize biosim to J&J`s Stelara
12 Sep 2023 //
FIERCE PHARMA
Novartis adjusts business unit names in preparation for Sandoz generics
08 Sep 2023 //
ENDPTS
AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others
31 Oct 2022 //
ENDPTS
Sandoz Resolves Legacy Federal Government Civil Investigation in the U.S
01 Oct 2021 //
GLOBENEWSWIRE
Sandoz announces generic Treprostinil Injection now also available f
24 May 2021 //
PRNEWSWIRE
Novartis` Sandoz embarks on €150M antibiotics manufacturing upgrade in Europe
19 May 2021 //
FIERCE PHARMA
Novartis sues FDA, claiming Sanofi`s Aubagio isn`t really new
12 Mar 2021 //
FIERCE PHARMA
Sandoz launches generic Icatibant in US for rare disease hereditary angioedema
28 Jan 2021 //
PRNEWSWIRE
Sandoz generic injectable acetaminophen immediately available to US patients
08 Dec 2020 //
PRNEWSWIRE
Attorneys general bring another ‘collusion’ case against generic makers
12 Jun 2020 //
ENDPTS
States file 3rd generics price-fixing suit against 26 firms
11 Jun 2020 //
FIERCEPHARMA
Pressure on generic drugmakers increases with new price fixing lawsuit
10 Jun 2020 //
BIOPHARMADIVE
Novartis shells out $195M in generics price-fixing settlement
03 Mar 2020 //
FIERCE PHARMA
Adamas Announces Settlement of Patent Litigation with Sandoz Inc.
03 Jan 2020 //
GLOBENEWSWIRE
Aurobindo is finding it difficult to satisfy the FDA, or the FTC
07 Nov 2019 //
FIERCE PHARMA
Sandoz-Aurobindo, Zolgensma, AZ and more
25 Oct 2019 //
FIERCE PHARMA
Where is that Sandoz U.S. generics deal with Aurobindo?
24 Oct 2019 //
FIERCE PHARMA
Digital Dose Inhalers Market-Opportunities With AstraZeneca, Novartis,Technavio
20 Sep 2019 //
BUSINESSWIRE
Novartis, Lonza deepen biosimilars push with MS, arthritis drug deals
04 Sep 2019 //
REUTERS
Pfizer`s Lyrica market share crumbles under generic onslaught
20 Aug 2019 //
FIERCE PHARMA
Lawmakers urge DoJ to get moving on generic price fixing probe
17 Jun 2019 //
FIERCE PHARMA
AstraZeneca`s Faslodex gets U.S. generic on heels of record sales year
31 May 2019 //
FIERCE PHARMA
Sandoz is 1st multinational secure generic approval under new Chinese guidelines
20 May 2019 //
PHARMAFILE
Generics `cartel` reaped billions from price fixing: lawsuit
14 May 2019 //
FIERCE PHARMA
In lawsuit, United Therapeutics is accused of unfairly blocking generic rival
22 Apr 2019 //
POST
Sandoz takes United Therapeutics to court for `anticompetitive` behavior
21 Apr 2019 //
BIOPHARMADIVE
Old guard` generics players yield U.S. scripts lead
18 Apr 2019 //
FIERCE PHARMA
Amid spinoff talk, Novartis generics biz licenses Shionogi brand
11 Apr 2019 //
FIERCE PHARMA
United kills its PhIII PAH drug after it fails Tyvaso combo study
09 Apr 2019 //
ENDPTS
Generics take aim at United`s top-selling Remodulin
28 Mar 2019 //
FIERCE PHARMA
Novartis generics boss quits amid conjecture over business’s future
14 Mar 2019 //
CNBC
Sandoz Inc. launches authorized generic version of buprenorphine and naloxone
19 Feb 2019 //
PR NEWSWIRE
Janumet (metformin hydrochloride; sitagliptin phosphate): Merck vs. Sandoz
15 Feb 2019 //
PATENT LITIGATION
Manufacturing cuts likely in remake of Sandoz
02 Feb 2019 //
FIERCE PHARMA
‘De-intergration’ of Sandoz from Novartis expected to include manufacturing cuts
01 Feb 2019 //
FIERCE PHARMA
Sandoz launches EpiPen rival at $250 per two-pack
18 Jan 2019 //
BIOPHARMA DIVE
Sandoz Inc. launches SYMJEPI™ (epinephrine) in the US
18 Jan 2019 //
PR NEWSWIRE
Investigation of generic ‘cartel’ expands to 300 drugs
09 Dec 2018 //
WASHINGTON POST
Sandoz prepares early 2019 launch for EpiPen alternative Symjepi at 16% discount
07 Dec 2018 //
FIERCE PHARMA
Correction: Cheaper EpiPen Rival story
07 Dec 2018 //
AP NEWS
Novartis plans more ‘autonomy’ for Sandoz. But NO spinoff
15 Nov 2018 //
FIERCE PHARMA
Vasostrict (Vasopressin) : Par Pharmaceutical vs. Sandoz Inc.
19 Oct 2018 //
PATENT LITIGATION
AbbVie settles Humira biosimilar dispute with Fresenius Kabi
19 Oct 2018 //
REUTERS
AbbVie Announces Resolution of HUMIRA® (adalimumab) Patent Dispute with Sandoz
12 Oct 2018 //
PR NEWSWIRE
Novartis` Gilenya tops Teva giant Copaxone in head-to-head MS study
11 Oct 2018 //
FIERCE PHARMA
Abbvie settles Humira patent disputes with Novartis unit
11 Oct 2018 //
REUTERS
Novartis` Gilenya tops Teva giant Copaxone in head-to-head MS study
11 Oct 2018 //
FIERCE PHARMA
Novartis` Gilenya tops Teva giant Copaxone in head-to-head MS study
11 Oct 2018 //
FIERCE PHARMA
Sandoz launches second digital health competition
04 Oct 2018 //
Humira (Adalimumab) : AbbVie Inc. et al v. Sandoz Inc. et al
11 Aug 2018 //
PATENT LITIGATION
Lawmaker urges Pfizer to sue over lethal injection procedure
30 Jul 2018 //
FIERCE PHARMA
